drugset / Trial / NCT01868646
Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The purpose of this study is: * to assess clinical efficacy of Subetta in the combined treatment of type II diabetes mellitus; * to assess safety of Subetta in the combined treatment of type II diabetes mellitus.
Timeline
- Start
- 2013-05-07
- Primary completion
- 2016-06-15
- Completion
- 2016-06-15
Outcome
Met primary endpoint
registry analysis (superiority test); Subetta vs Placebo; p = 0.0002; Mixed Models Analysis NCT01868646 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Subetta | Protein / enzyme biologic | 1 unknown | Oral |